Survodutide and cotadutide are synthetic peptides studied for their activity at both glucagon-like peptide-1 (GLP-1) and glucagon receptors. Although they belong to the same broad pharmacological category, they are distinct molecular entities.
For UK laboratories comparing Survodutide vs Cotadutide, receptor pharmacology, molecular identity and batch-specific analytical evidence are more useful than broad claims about metabolic activity.
Survodutide vs Cotadutide: Scientific Differences
Survodutide, also known as BI 456906, is a modified GLP-1/glucagon dual-receptor agonist studied in metabolic and liver-related research.
Cotadutide, previously known as MEDI0382, is another dual-receptor agonist examined in metabolic research.
Both compounds interact with GLP-1 and glucagon receptor systems, but their peptide sequences, structural modifications and receptor activity profiles differ.
| Research characteristic | Survodutide | Cotadutide |
|---|---|---|
| Development identifier | BI 456906 | MEDI0382 |
| Compound class | Dual-receptor peptide agonist | Dual-receptor peptide agonist |
| Receptor targets | GLP-1 and glucagon | GLP-1 and glucagon |
| Molecular identity | Compound-specific sequence and modifications | Distinct sequence and modifications |
| Functional assessment | Receptor-specific activity assays | Receptor-specific activity assays |
| Procurement priority | Identity and batch verification | Identity and batch verification |
The shared receptor targets do not establish equivalent potency or experimental behaviour.
Five Specifications UK Research Buyers Should Compare
1. Molecular Identity
Request the complete peptide identity, expected molecular mass and relevant chemical modifications.
A supplier listing that identifies a product only as a dual agonist does not establish which compound is supplied.
2. Receptor Activity Evidence
Where experimental work depends on receptor responses, examine functional assay data for both GLP-1 and glucagon receptors.
Assay conditions and reference standards matter when interpreting reported potency.
3. Purity and Peptide Content
HPLC can assess chromatographic purity, while mass spectrometry can support molecular identity.
Neither result alone establishes actual peptide content by mass or biological potency.
4. Powder and Solution Formats
For lyophilised powders, verify peptide content, excipients and documented storage conditions.
Prepared solutions require additional information about concentration, solvent composition, fill volume and stability.
5. Batch-Specific Documentation
A suitable certificate of analysis should identify the batch, analytical methods, results and relevant acceptance criteria.
Review our GLP-1 and glucagon dual-agonist comparison and cotadutide supplier documentation guide for additional procurement considerations.
Frequently Asked Questions
1. Are survodutide and cotadutide identical?
No. They are distinct peptide compounds.
2. Do both target GLP-1 receptors?
Yes. Both have GLP-1 receptor agonist activity.
3. Do both target glucagon receptors?
Yes. Both are studied as dual agonists.
4. Does equal purity mean equal potency?
No. Potency requires appropriate functional testing.
5. Can their storage requirements differ?
Yes. Formulation and stability characteristics may differ.
6. Should buyers request batch-specific COAs?
Yes. They support analytical assessment and traceability.
Conclusion
The main consideration in Survodutide vs Cotadutide is that shared receptor targets do not make the compounds interchangeable. UK laboratories should compare molecular identity, receptor activity evidence, formulation specifications and batch documentation.
For laboratory research only. Not intended for human administration or clinical use.
Scientific and Technical References
- PubMed — Survodutide research: https://pubmed.ncbi.nlm.nih.gov/?term=survodutide
- PubMed — Cotadutide and MEDI0382 research: https://pubmed.ncbi.nlm.nih.gov/?term=cotadutide+MEDI0382
- ICH Q2(R2) — Validation of Analytical Procedures: https://www.ich.org/page/quality-guidelines
These references provide scientific and analytical context, not verification of individual supplier products.